procainamide has been researched along with Leukemia P388 in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esposito, M | 1 |
| Viale, M | 1 |
| Vannozzi, MO | 1 |
| Zicca, A | 1 |
| Cadoni, A | 1 |
| Merlo, F | 1 |
| Gogioso, L | 1 |
1 other study available for procainamide and Leukemia P388
| Article | Year |
|---|---|
Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
Topics: Animals; Anti-Arrhythmia Agents; Antineoplastic Agents; Cisplatin; Drug Synergism; Female; Kidney; L | 1996 |